wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33588875-49F2B5F3-AC41-4BDC-8BFE-A67C42FC5422
Q33588875-49F2B5F3-AC41-4BDC-8BFE-A67C42FC5422
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588875-49F2B5F3-AC41-4BDC-8BFE-A67C42FC5422
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
P2860
Q33588875-49F2B5F3-AC41-4BDC-8BFE-A67C42FC5422
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33588875-49F2B5F3-AC41-4BDC-8BFE-A67C42FC5422
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3de534cfafc5ebd47ebd462f20ebe851d283e424
P2860
bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer.